It was indicated that higher expression of CD47 predicted poor survival in ACC, KICH, KIRP, LGG, PAAD, and UCEC, while associated with favorable prognosis in SKCM, THCA, and THYM (Fig. 2A). This evidence concerns the gene CD47 and adrenal cortex carcinoma.